WO2000015175A3 - Use as an active substance of molecules binding to beta-1-integrin with the capacity to kill cells - Google Patents
Use as an active substance of molecules binding to beta-1-integrin with the capacity to kill cells Download PDFInfo
- Publication number
- WO2000015175A3 WO2000015175A3 PCT/SE1999/001560 SE9901560W WO0015175A3 WO 2000015175 A3 WO2000015175 A3 WO 2000015175A3 SE 9901560 W SE9901560 W SE 9901560W WO 0015175 A3 WO0015175 A3 WO 0015175A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- capacity
- integrins
- kill cells
- active substance
- integrin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU62357/99A AU6235799A (en) | 1998-09-10 | 1999-09-08 | New use |
EP99949501A EP1112078A2 (en) | 1998-09-10 | 1999-09-08 | New use |
JP2000569760A JP2003527307A (en) | 1998-09-10 | 1999-09-08 | New use |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9803098-4 | 1998-09-10 | ||
SE9803098A SE9803098D0 (en) | 1998-09-10 | 1998-09-10 | new use |
US13579899P | 1999-05-24 | 1999-05-24 | |
US60/135,798 | 1999-05-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000015175A2 WO2000015175A2 (en) | 2000-03-23 |
WO2000015175A3 true WO2000015175A3 (en) | 2000-07-13 |
Family
ID=26663397
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/SE1999/001560 WO2000015175A2 (en) | 1998-09-10 | 1999-09-08 | Use as an active substance of molecules binding to beta-1-integrin with the capacity to kill cells |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1112078A2 (en) |
JP (1) | JP2003527307A (en) |
AU (1) | AU6235799A (en) |
WO (1) | WO2000015175A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3412686A1 (en) | 2003-10-17 | 2018-12-12 | AlJamal-Naylor, Rehab | Tissue repair by modulation of beta-1 integrin biological function |
US20060217308A1 (en) * | 2005-03-10 | 2006-09-28 | Pascale Cossart | Compositions for the treatment of tumor pathologies, comprising internalin B (ln1B) of Listeria monocytogene protein or a fragment thereof |
JP2007008895A (en) * | 2005-07-04 | 2007-01-18 | Chugai Pharmaceut Co Ltd | Combined use of anti-cd47 antibody and integrin ligand |
GB0703652D0 (en) | 2007-02-26 | 2007-04-04 | Univ Bradford | Method for the allosteric modulation of beta1 integrin |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996013250A1 (en) * | 1994-10-27 | 1996-05-09 | Amgem Inc. | Compositions for increased bioavailability of orally delivered therapeutic agents |
US5846536A (en) * | 1996-10-04 | 1998-12-08 | The Regents Of The University Of California | Restoration of normal phenotype in cancer cells |
-
1999
- 1999-09-08 EP EP99949501A patent/EP1112078A2/en not_active Withdrawn
- 1999-09-08 WO PCT/SE1999/001560 patent/WO2000015175A2/en not_active Application Discontinuation
- 1999-09-08 AU AU62357/99A patent/AU6235799A/en not_active Abandoned
- 1999-09-08 JP JP2000569760A patent/JP2003527307A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996013250A1 (en) * | 1994-10-27 | 1996-05-09 | Amgem Inc. | Compositions for increased bioavailability of orally delivered therapeutic agents |
US5846536A (en) * | 1996-10-04 | 1998-12-08 | The Regents Of The University Of California | Restoration of normal phenotype in cancer cells |
Non-Patent Citations (3)
Title |
---|
DATABASE MEDLINE, [online] MITRA R.S. ET AL.: "Apoptosis in keratinocytes is not dependent on induction of differentiation", XP002944349, accession no. Dialog Database accession no. 9010453 * |
LAB. INVEST., vol. 76, no. 1, January 1997 (1997-01-01), pages 99 - 107 * |
NANCY BOUDREAU ET AL.: "Suppression of ICE and Apoptosis in Mammary Epithelial Cells by Extracellular Matrix", SCIENCE,, vol. 267, 10 February 1995 (1995-02-10), pages 891 - 893, XP002925810 * |
Also Published As
Publication number | Publication date |
---|---|
WO2000015175A2 (en) | 2000-03-23 |
AU6235799A (en) | 2000-04-03 |
EP1112078A2 (en) | 2001-07-04 |
JP2003527307A (en) | 2003-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID30111A (en) | SHEETS THAT CAN BE OBTAINED LIQUID FOR THE BODY ABSORPTION ABSORPTION MATERIAL, APARATUS AND THE PRODUCTION METHOD (Fraction from NO. P970605) | |
MA26508A1 (en) | PHARMACEUTICAL FORMULATIONS CONTAINING VARICONAZOLE, AND PROCESS FOR THEIR PREPARATION. | |
EA200200105A1 (en) | Compounds modulating PPARγ activity; | |
WO1998051712A1 (en) | Chitin beads, chitosan beads, processes for producing these beads, carriers made of these beads and processes for producing microsprodidian spores | |
CA2362251A1 (en) | Methods for preserving dna integrity | |
AU5210798A (en) | Nucleic acid construct for expressing active substances which can be activated by proteases, and preparation and use | |
CA2276747A1 (en) | Methods and devices for the reduction of small organic compounds from blood products | |
AU2374100A (en) | Products comprising trihydroxystilbenes and derivatives thereof and methods for their manufacture and use | |
WO2000015175A3 (en) | Use as an active substance of molecules binding to beta-1-integrin with the capacity to kill cells | |
AU5143099A (en) | Protein fragment complementation assays for the detection of biological or drug interactions | |
AU4943496A (en) | Process and compounds for detection of analytes using remanence measurement, and use thereof | |
AU7987398A (en) | One step device and process for concentration and purification of biological molecules | |
WO1999039009A8 (en) | Processes for isolating, amplifying and characterizing dna | |
AU5634099A (en) | Composition for the removal of biological and organic substances | |
AU3258097A (en) | Pharmaceutical composition containing an embryonic or gravid uterus extract as an active substance and relative preparation process | |
AU7595298A (en) | Azolidinediones useful for the treatment of diabetes, dyslipidemia and hy pertension | |
AU4779599A (en) | Methods of inhibiting (helicobacter pylori) | |
ZA987412B (en) | 3-Arylsuccinamidohydroxamic acids, processes for their preparation, and drugs containing these substances. | |
FR2755438B1 (en) | COMPOUND, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | |
AU5186396A (en) | Hematophagous insect calreticulin nucleic acid molecules, proteins and uses thereof | |
WO1998022508A3 (en) | Process for tumour cell depletion of cd34-positive cells | |
FR2777751B1 (en) | PROTEIN SUPPLEMENT, FOOD COMPOSITION CONTAINING THE SAME, PROCESS FOR THEIR PREPARATION AND THEIR USE. | |
FR2741087B1 (en) | ADENOVIRAL DODECAEDRIC PROTEIN COMPLEX, PREPARATION METHOD, COMPOSITION CONTAINING THE SAME AND ITS APPLICATIONS | |
AU2151697A (en) | Increased yields of a crystallized protein by using a solid adsorption material | |
WO2002055550A3 (en) | Crystallization and structure determination of fema and/or fema-like proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 569760 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999949501 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09786770 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1999949501 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999949501 Country of ref document: EP |